| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 11/30/2005 | EP1599432A1 Adamantane derivatives, processes for their preparation and pharmaceutical composition containing them |
| 11/30/2005 | EP1599227A2 Methods of immunomodulation in animals |
| 11/30/2005 | EP1599202A1 Tetracyclic pyrazole derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 11/30/2005 | EP1289534B1 Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders |
| 11/30/2005 | EP1274457B1 Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists |
| 11/30/2005 | EP1224185B1 Thiazole and imidazo[4,5-b]pyridine compounds and their pharmaceutical use |
| 11/30/2005 | EP1221941A4 Powder pharmaceutical formulations |
| 11/30/2005 | EP1176981B1 Treatment of autoimmune diseases with antagonists which bind to b cell surface markers |
| 11/30/2005 | EP1144372B1 Sulphohydroxamic acids and sulphohydroxamates and their use as mek inhibitors |
| 11/30/2005 | EP1091943B1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 11/30/2005 | EP1079832B1 Use of vitamin pp compounds |
| 11/30/2005 | EP0963200B9 Compositions for inhibition of angiogenesis comprising thalodomide and a nsaid |
| 11/30/2005 | EP0891377B1 Inhibitor and stimulator of haematopoietic stem cell proliferation and uses thereof |
| 11/30/2005 | CN1703428A Peptides modulating caspase activation |
| 11/30/2005 | CN1703427A Methods and compositions to generate and control the effector profile of T cells by simultaneous loading and activation of selected subsets of antigen presenting cells |
| 11/30/2005 | CN1703425A Crystallization of IGF-1 |
| 11/30/2005 | CN1703395A Aryl and heteroaryl compounds and methods to modulate coagulation |
| 11/30/2005 | CN1703238A Recombinant intracellular pathogen immunogenic compositions and methods for use |
| 11/30/2005 | CN1703234A The use of low-molecular-weight thrombin inhibitor |
| 11/30/2005 | CN1703197A Injectable depot compositions and uses thereof |
| 11/30/2005 | CN1701791A Medicine for treating allergic skin disease and its preparation process |
| 11/30/2005 | CN1229501C Mixture of recombinant vaccinia vectors as poly-envelope protein vaccines for HIV |
| 11/30/2005 | CN1229391C Antibody of human gastrointestinal epithelial tumor antigen related to alpha 6 beta 4 integrin |
| 11/30/2005 | CN1229388C N-terminal modified protein compositions and methods therefor |
| 11/30/2005 | CN1229381C Macrolides compound |
| 11/30/2005 | CN1229373C Piperidinee derivatives as neurokinin1 antagonists |
| 11/30/2005 | CN1229353C Method and compositions utilizing quinazolinones |
| 11/30/2005 | CN1229351C Heterocyclic compounds and methods to treat cardiac failure and other disorders |
| 11/30/2005 | CN1229349C Pyridine-3-carboxylic acid derivative |
| 11/30/2005 | CN1229343C Chemotactic factor receptor active regulator |
| 11/30/2005 | CN1229335C Nervinolin derivatives |
| 11/30/2005 | CN1229334C Inhibitors of alpha4 mediated cell adhesion |
| 11/30/2005 | CN1229331C Inhibitor of monoamine uptake |
| 11/30/2005 | CN1229114C Method of treating ciliary dyskinesia with uridine triphosphates and related compounds |
| 11/30/2005 | CN1229113C A Pharmaceutical composition for the treatment of autoimmune diseases |
| 11/30/2005 | CN1229111C Sustained release preparations |
| 11/29/2005 | US6969770 reacting an alpha-keto carboxy acid ester or derivative with a pyrrolidinone to form an intermediate, subjecting the intermediate to asymmetric hydrogenation using a chiral catalyst to form the end product |
| 11/29/2005 | US6969760 Jak kinases and regulation of cytokine signal transduction |
| 11/29/2005 | US6969729 An indole or benz(g)indole-2,3-dione-3-oxime compounds; therapeutic treatment of respiratory disorders, urogenital disorders, cardiovascular disorders, brain and psychological disorders, gastrointestinal disorders |
| 11/29/2005 | US6969728 Antiinflammatory agents |
| 11/29/2005 | US6969723 preferably antagonists used in the therapeutic and/or preventive treatment of disfunctions of the heart, kidney, respiratory system, central nervous system |
| 11/29/2005 | US6969720 2,6,9-trisubstituted purine derivatives which are inhibitors of cyclin/cdk (cyclin dependent kinases) complexes |
| 11/29/2005 | US6969719 Such as 3-((3-bromo-4-hydroxyphenyl)methyl)-5-ethyl-7,8-dihydro-2-(tetrahydro-2H -pyran-4-yl)amino)-3H-imidazo(2,1-b) purin-4(5H)-one for treating sexual disorders |
| 11/29/2005 | US6969717 Azaindole kinase inhibitors |
| 11/29/2005 | US6969714 Imidazolo-5-YL-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation |
| 11/29/2005 | US6969713 Piperidine and piperazine acetamide derivatives |
| 11/29/2005 | US6969708 Process for the preparation of a high purity composition comprising (7α, 17α)- 17-hydroxy- 7-methyl- 19-nor-17-pregn-5(10)-en-20-yn-3-one |
| 11/29/2005 | US6969707 For therapy or inhibiting the development of a pathology associated with peroxynitrite damage |
| 11/29/2005 | US6969517 Anticancer agents; genetic engineered fusion protein |
| 11/29/2005 | CA2367013C Metered dose inhaler for fluticasone propionate |
| 11/29/2005 | CA2288445C 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives |
| 11/29/2005 | CA2118329C Isolation, characterization, and use of the human .beta. subunit of the high affinity receptor for immunoglobulin e |
| 11/24/2005 | WO2004103271A3 Disease prevention and vaccination prior to thymic reactivations |
| 11/24/2005 | WO2004091630A8 Remedies for diseases to be applied to eye |
| 11/24/2005 | US20050261496 3-(Morpholin-4-ylsulfonyl)-5-(1,3-thiazol-2-yl)-1H-indole-2-carboxamide; inhibiting, modulating and/or regulating signal transduction of both receptor and non-receptor tyrosine kinases; anticarcinogenic, -diabetic, -arhtritic, -inflammatory agents; psoriasis; angiogenesisinhibitors; liver cirrhosis |
| 11/24/2005 | US20050261478 For activating T and/or B cells by aggregating three or more cell surface antigens; the activation signals may result in either immune enhancement or immunosuppression |
| 11/24/2005 | US20050261343 Anthranilamides and their use as pharmaceutical agents |
| 11/24/2005 | US20050261339 Jun N-terminal kinase inhibitors; neurodegenerative diseases; Alzheimer's disease; amyotrophic lateral sclerosis; multiple sclerosis; spinocerebellar ataxia |
| 11/24/2005 | US20050261333 Inhibitors of the kinase Itk; 2-aryl-substituted derivatives of 6-substituted-3H-imidazo[4,5-b]pyridines; to treat allergic, autoimmune, inflammatory, proliferative and hyperproliferative diseases and immune-mediated diseases; 6,7-dichloro-2-[4-(2-morpholin-4-ylethoxy)phenyl]-3H-imidazo[4,5-b]pyridine |
| 11/24/2005 | US20050261331 Substituted pyrrolopyridines |
| 11/24/2005 | US20050261317 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 11/24/2005 | US20050261305 Cyclic protein tyrosine kinase inhibitors |
| 11/24/2005 | US20050261301 e,g, 1,5-bis(5-acetyl-4,7-dimethoxybenzofuran-6-yloxy)pentane;potassium channel modulator; antiinflammatory agent, autoimmune diseases; immunosuppressant; multiple sclerosis, rejection of foreign organ transplants |
| 11/24/2005 | US20050261293 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 11/24/2005 | US20050261291 1-Cyclopropylmethyl-4-[2-(3,3,5,5-tetramethylcyclohexyl)phenyl]piperazine or a salt or hydrate; exhibit excellent cell adhesion inhibitory action or cell infiltration inhibitory action; for treating inflammatory diseases and autoimmune diseases such as inflammatory bowel diseases and rheumatoid arthritis |
| 11/24/2005 | US20050261281 Pharmaceutical compounds |
| 11/24/2005 | US20050261280 Stabilized antihistamine syrup |
| 11/24/2005 | US20050261271 Dipeptidyl peptidase inhibitors |
| 11/24/2005 | US20050261269 New derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 11/24/2005 | US20050261248 New-4-pyrrolopyrimidin-6-YL)benzenesulphonamide derivatives |
| 11/24/2005 | US20050261229 Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens |
| 11/24/2005 | US20050261169 Peptide and peptide mimetic derivatives having integrin inhibitor properties III |
| 11/24/2005 | US20050261163 Pharmaceutical products, preparation and uses thereof |
| 11/24/2005 | US20050260767 Treatment with cytokines |
| 11/24/2005 | US20050260753 Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants |
| 11/24/2005 | US20050260747 Embryonic stem cells and neural progenitor cells derived therefrom |
| 11/24/2005 | US20050260732 Polypeptide crystal having a polyhistidine tag added to the C-terminal end; effectors; drug screening for enzyme inhibitors; multiple sclerosis, diabetes, Grave's disease, rheumatic arthritis, AIDS, cancer, immunomodulators |
| 11/24/2005 | US20050260601 Recombinant mutants of rhabdovirus and methods of use thereof |
| 11/24/2005 | US20050260560 Administering antigens capable of causing specific immune reaction(s) directed against an infectious agent and/or cells infected with the infectious agent, and decreasing a different specific immune reaction direct towards the infectious agent, infected cells and/or uninfected cells; immunotherapy |
| 11/24/2005 | US20050260230 Leucine-based motifs and enhanced biological persistence of clostridial neurotoxins |
| 11/24/2005 | US20050260228 Vaccines absorbable by the transmucosal way |
| 11/24/2005 | US20050260227 Novel therapeutic processes for treating cancer with specific antigens |
| 11/24/2005 | US20050260226 Novel therapeutic processes for treating infectious agents by training or adoptive transfer of immune cells, and useful compositions therefor |
| 11/24/2005 | US20050260223 Salmonella vaccine materials and methods |
| 11/24/2005 | US20050260218 House dust mite allergen, Der f VII, and uses therefor |
| 11/24/2005 | US20050260192 Leukocyte function associated antigens comprising integrin I-domain for use in identifying modulators for prevention and treatment of inflammatory disorders; immunosuppressive agents |
| 11/24/2005 | US20050260174 Systems and methods for treating patients with processed lipoaspirate cells |
| 11/24/2005 | US20050259281 Method, apparatus and computer program for transforming digital colour images |
| 11/24/2005 | CA2812040A1 Antibodies |
| 11/24/2005 | CA2560108A1 Immunostimulatory nucleic acids for inducing il-10 responses |
| 11/24/2005 | CA2507712A1 Pharmaceutical compounds |
| 11/24/2005 | CA2507710A1 Tricyclic pyrazole derivatives and their use as cb1 or cb2 modulators |
| 11/23/2005 | EP1598425A1 Modified Vaccinia Ankara virus variant |
| 11/23/2005 | EP1598335A1 Prostaglandin derivatives |
| 11/23/2005 | EP1598079A1 Remedies for allergic contact dermatitis |
| 11/23/2005 | EP1597258A2 Novel purine derivatives, preparation method thereof, application of same as medicaments, pharmaceutical compositions and novel use |
| 11/23/2005 | EP1596885A2 Uses of anti-insulin-like growth factor i receptor antibodies |
| 11/23/2005 | EP1596807A2 Immune regulation based on the targeting of early activation molecules |
| 11/23/2005 | EP1596804A2 SOLUBLE FcyR FUSION PROTEINS AND METHODS OF USE THEREOF |
| 11/23/2005 | EP1383872B1 Genetically modified yt cell line and use thereof |